[Source: Research & Innovation] Leaders in the field will discuss recent developments in lung cancer research and how to translate them into clinical application. Topics include personalized immunotherapy, clonal heterogeneity and resistance, undruggable mutations, targeted therapy of SCLC and current developments in predictive diagnostics. The meeting will be highly interactive with a strong focus on discussion.
from EUROPA - Syndicated Research News Feed http://ift.tt/2fuUrFz
via IFTTT
No comments:
Post a Comment